Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Money Market Investments
$-62.14 Mil (As of Dec. 2013)

Synageva BioPharma Corp's money market investment for the quarter that ended in Dec. 2013 was $-62.14 Mil. It means Synageva BioPharma Corp paid $62.14 Mil to invest on the money market.

Compared with last quarter ($-216.87 Mil in Sep. 2013 ), Synageva BioPharma Corp paid less money to invest on the money market in Dec. 2013 ($-62.14 Mil).


Definition

Money Market Investments carried on banks' balance sheet.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_MoneyMarket -28.10-23.56-30.05-32.70-14.39-47.42-14.72-60.23-23.88-62.14

Synageva BioPharma Corp Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
BS_MoneyMarket -52.39-60.23-138.92-138.86-233.41-23.88-53.76-47.76-216.87-62.14
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide